Biktarvy, formally known as bictegravir sulfate, includes a potent single-tablet regimen for controlling HIV infection. This formula unites three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the HIV's ability to multiply within the body, significantly reducing the viral load. For many